Iván Dlouhy

1.7k total citations
26 papers, 557 citations indexed

About

Iván Dlouhy is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Iván Dlouhy has authored 26 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 14 papers in Oncology and 12 papers in Genetics. Recurrent topics in Iván Dlouhy's work include Lymphoma Diagnosis and Treatment (23 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Viral-associated cancers and disorders (8 papers). Iván Dlouhy is often cited by papers focused on Lymphoma Diagnosis and Treatment (23 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Viral-associated cancers and disorders (8 papers). Iván Dlouhy collaborates with scholars based in Spain, Chile and Italy. Iván Dlouhy's co-authors include Elı́as Campo, Armando López‐Guillermo, Antonio Martı́nez, Laura Magnano, Eva Giné, Jordina Rovira, Alejandra Martínez‐Trillos, Julio Delgado, María Elena Cabrera and Massimo Federico and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Iván Dlouhy

24 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iván Dlouhy Spain	12	437	311	150	130	99	26	557
Anna Gazzola Italy	12	460 1.1×	327 1.1×	220 1.5×	112 0.9×	111 1.1×	43	649
Maria Delioukina United States	13	426 1.0×	308 1.0×	168 1.1×	168 1.3×	157 1.6×	33	652
Greg Dueck Canada	9	475 1.1×	344 1.1×	168 1.1×	229 1.8×	56 0.6×	13	570
Colin Phipps Singapore	8	353 0.8×	344 1.1×	250 1.7×	58 0.4×	73 0.7×	17	543
Naohiro Sekiguchi Japan	12	400 0.9×	254 0.8×	102 0.7×	209 1.6×	86 0.9×	61	570
Darius Juškevičius Switzerland	13	427 1.0×	277 0.9×	97 0.6×	171 1.3×	73 0.7×	32	560
Natalie Dimier United Kingdom	10	385 0.9×	380 1.2×	137 0.9×	205 1.6×	257 2.6×	20	747
Manuel F. Rosado United States	10	333 0.8×	249 0.8×	87 0.6×	97 0.7×	58 0.6×	14	491
Helle Toldbod Denmark	9	513 1.2×	405 1.3×	244 1.6×	145 1.1×	191 1.9×	13	804
Juan Pablo Alderuccio United States	13	538 1.2×	487 1.6×	99 0.7×	159 1.2×	60 0.6×	79	749

Countries citing papers authored by Iván Dlouhy

Since Specialization

Citations

This map shows the geographic impact of Iván Dlouhy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iván Dlouhy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iván Dlouhy more than expected).

Fields of papers citing papers by Iván Dlouhy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iván Dlouhy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iván Dlouhy. The network helps show where Iván Dlouhy may publish in the future.

Co-authorship network of co-authors of Iván Dlouhy

This figure shows the co-authorship network connecting the top 25 collaborators of Iván Dlouhy. A scholar is included among the top collaborators of Iván Dlouhy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iván Dlouhy. Iván Dlouhy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hapgood, Greg, Monica Civallero, Julie M. Vose, et al.. (2023). The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network. Blood Advances. 7(17). 5047–5054. 1 indexed citations

Martı́n, Alejandro, Mónica Baile, Guillermo Rodríguez‐Domínguez, et al.. (2023). Lenalidomide in combination with R‐ESHAP in patients with relapsed or refractory diffuse large B‐cell lymphoma: A phase 2 study from GELTAMO. British Journal of Haematology. 203(2). 202–211.

Advani, Ranjana H., Tetiana Skrypets, Monica Civallero, et al.. (2021). Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project. Blood. 138(3). 213–220. 60 indexed citations

Mozas, Pablo, Alfredo Rivas‐Delgado, Andrea Rivero, et al.. (2020). High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era. Leukemia Research. 94. 106371–106371. 11 indexed citations

Foss, Francine M., Steven M. Horwitz, Monica Civallero, et al.. (2019). Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas. American Journal of Hematology. 95(2). 151–155. 38 indexed citations

Bellei, Monica, Francine M. Foss, Andrei R. Shustov, et al.. (2018). The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project. Haematologica. 103(7). 1191–1197. 88 indexed citations

Rivas‐Delgado, Alfredo, Laura Magnano, Olga García, et al.. (2018). Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era. British Journal of Haematology. 184(5). 753–759. 44 indexed citations

Valero, Juan García, Aránzazu Chamorro-Jorganes, David G. Gonzalez, et al.. (2018). The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma. Oncogene. 37(14). 1830–1844. 58 indexed citations

Foss, Francine M., Steven M. Horwitz, Monica Bellei, et al.. (2017). Outcome of Patients with Gamma Delta T Cell Lymphomas: Analysis of 1429 Cases Registered in the Prospective T-Cell Project. Blood. 130. 1512–1512. 3 indexed citations

10.

Dlouhy, Iván, Xavier Filella, Jordina Rovira, et al.. (2017). High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma. Leukemia Research. 59. 20–25. 38 indexed citations

11.

Magnano, Laura, Olga Balagué, Iván Dlouhy, et al.. (2017). Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma. Annals of Oncology. 28(11). 2799–2805. 20 indexed citations

12.

Rivas‐Delgado, Alfredo, Laura Magnano, Pablo Mozas, et al.. (2017). Progression‐free survival shortens after each relapse in patients with follicular lymphoma treated in the rituximab era. Hematological Oncology. 35(S2). 360–361. 4 indexed citations

13.

Rovira, Jordina, Kennosuke Karube, Alexandra Valera, et al.. (2016). MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome. Clinical Cancer Research. 22(11). 2755–2764. 50 indexed citations

14.

Dlouhy, Iván, Sabela Lens, Jordina Rovira, et al.. (2016). Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Annals of Hematology. 96(3). 405–410. 12 indexed citations

15.

Valera, Alexandra, Luís Colomo, Alice Riva, et al.. (2016). Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression. Modern Pathology. 29(8). 844–853. 6 indexed citations

16.

Magnano, Laura, Antonio Martı́nez, Joaquim Carreras, et al.. (2016). T-cell subsets in lymph nodes identify a subgroup of follicular lymphoma patients with favorable outcome. Leukemia & lymphoma. 58(4). 842–850. 4 indexed citations

17.

Bellei, Monica, Elena Sabattini, Emanuela Pesce, et al.. (2016). Pitfalls and major issues in the histologic diagnosis of peripheral T‐cell lymphomas: results of the central review of 573 cases from the T‐Cell Project, an international, cooperative study. Hematological Oncology. 35(4). 630–636. 13 indexed citations

18.

Rovira, Jordina, Alexandra Valera, Luís Colomo, et al.. (2014). Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy. Annals of Hematology. 94(5). 803–812. 71 indexed citations

19.

Delgado, Julio, Gabriela Ghita, Tycho Baumann, et al.. (2013). Rituximab-Based Chemoimmunotherapy Prolongs Survival of Patients With Chronic Lymphocytic Leukemia Independently of the Time of Administration. Clinical Lymphoma Myeloma & Leukemia. 14(1). 73–79. 3 indexed citations

20.

Dlouhy, Iván, Gabriela Ghita, Tycho Baumann, et al.. (2012). Retreatment with purine analogs in patients with chronic lymphocytic leukemia. Leukemia Research. 36(12). 1521–1525. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact